EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression

Gu, Jian-Wei; Makey, Kristina L.; Tucker, Kevan B.; Chinchar, Edmund; Mao, Xiaowen; Pei, Ivy; Thomas, Emily Y.; Miele, Lucio
June 2013
Vascular Cell;2013, Vol. 5 Issue 1, p1
Academic Journal
The role of EGCG, a major green tea catechin in breast cancer therapy is poorly understood. The present study tests the hypothesis that EGCG can inhibit the activation of HIF-1α and NFκB, and VEGF expression, thereby suppressing tumor angiogenesis and breast cancer progression. Sixteen eight-wk-old female mice (C57BL/6 J) were inoculated with 10∧6 E0771 (mouse breast cancer) cells in the left fourth mammary gland fat pad. Eight mice received EGCG at 50-100 mg/kg/d in drinking water for 4 weeks. 8 control mice received drinking water only. Tumor size was monitored using dial calipers. At the end of the experiment, blood samples, tumors, heart and limb muscles were collected for measuring VEGF expression using ELISA and capillary density (CD) using CD31 immunohistochemistry. EGCG treatment significantly reduced tumor weight over the control (0.37 ± 0.15 vs. 1.16 ± 0.30 g; P < 0.01), tumor CD (109 ± 20 vs. 156 ± 12 capillary #/mm∧2; P < 0.01), tumor VEGF expression (45.72 ± 1.4 vs. 59.03 ± 3.8 pg/mg; P < 0.01), respectively. But, it has no effects on the body weight, heart weight, angiogenesis and VEGF expression in the heart and skeletal muscle of mice. EGCG at 50 μg/ml significantly inhibited the activation of HIF-1α and NFκB as well as VEGF expression in cultured E0771 cells, compared to the control, respectively. These findings support the hypothesis that EGCG, a major green tea catechin, directly targets both tumor cells and tumor vasculature, thereby inhibiting tumor growth, proliferation, migration, and angiogenesis of breast cancer, which is mediated by the inhibition of HIF-1α and NFκB activation as well as VEGF expression.


Related Articles

  • Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds. Fujiki, Hirota; Sueoka, Eisaburo; Watanabe, Tatsuro; Suganuma, Masami // Journal of Cancer Research & Clinical Oncology;Sep2015, Vol. 141 Issue 9, p1511 

    Purpose: In 2008, we reported that 10 Japanese-size cups of green tea daily, supplemented with tablets of green tea extract (GTE), reduced the recurrence of colorectal adenoma by 51.6 % in patients after polypectomy. Based on these results, we paid special attention to Japanese cancer patients,...

  • Antiallodynic effect of intrathecal epigallocatechin-3-gallate due to suppression of reactive oxygen species. Sang Soon An; Yeo Ok Kim; Cheon Hee Park; Hai Lin; Myung Ha Yoon // Korean Journal of Anesthesiology;Aug2014, Vol. 67 Issue 2, p123 

    Background: Green tea modulates neuropathic pain. Reactive oxygen species (ROS) are suggested as a key molecule in the underlying mechanism of neuropathic pain in the spinal cord. We examined the effect of epigallocatechin-3-gallate (EGCG), the major catechin in green tea, in neuropathic pain...

  • Green Tea Polyphenols as Proteasome Inhibitors: Implication in Chemo-prevention. Yang, H.; Landis-Piwowar, K.; Chan, T. H.; Dou, Q. P. // Current Cancer Drug Targets;Mar2011, Vol. 11 Issue 3, p296 

    No abstract available.

  • Environmental Medicine Update. Marchese, Marianne // Townsend Letter;Dec2012, Issue 353, p32 

    The article focuses on several integrative treatments and medicines for multiple sclerosis (MS). It mentions green tea as one of the integrative treatments for MS as its main constituent is the epigallocatechin-3-gallate (EGCG) as it limits brain inflammation and lessens neuronal damage. It also...

  • Metabolic Profiling-based Data-mining for an Effective Chemical Combination to Induce Apoptosis of Cancer Cells. Kumazoe, Motofumi; Fujimura, Yoshinori; Hidaka, Shiori; Kim, Yoonhee; Murayama, Kanako; Takai, Mika; Huang, Yuhui; Yamashita, Shuya; Murata, Motoki; Miura, Daisuke; Wariishi, Hiroyuki; Maeda-Yamamoto, Mari; Tachibana, Hirofumi // Scientific Reports;3/27/2015, p9474 

    Green tea extract (GTE) induces apoptosis of cancer cells without adversely affecting normal cells. Several clinical trials reported that GTE was well tolerated and had potential anti-cancer efficacy. Epigallocatechin-3-O-gallate (EGCG) is the primary compound responsible for the anti-cancer...

  • Drug made from green tea could help slow prostate cancer.  // Urology Times;Nov2009, Vol. 37 Issue 12, p58 

    The article reports on the relevance of green tea with prostrate cancer based on the study conducted by researchers in Shreveport, Louisiana. according to the study, catechins in green tea helps slow the development of prostate cancer. It states that patients were given daily doses of the...

  • Mayo Clinic Finds Green Tea Extract Fights Leukemia. Dye, Dayna // Life Extension;Sep2009, Vol. 15 Issue 9, p21 

    The article presents a study, conducted Mayo Clinic researchers, that shows the use of green tea extract in fighting leukemia. In an article appeared in the "Journal of Clinic Oncology," researchers account positive effects for epigallocatechin gallate (EGCG) in a phase I trial involving early...

  • Green tea extracts attenuate doxorubicin-induced spermatogenic disorders in conjunction with higher telomerase activity in mice. Sato, Kenji; Sueoka, Kou; Tanigaki, Reiko; Tajima, Hiroto; Nakabayashi, Akira; Yoshimura, Yasunori; Hosoi, Yoshihiko // Journal of Assisted Reproduction & Genetics;Aug2010, Vol. 27 Issue 8, p501 

    Purpose: The aim of this study was to investigate the protective effect of green tea extracts against doxorubicin-induced damage in the mouse testes correlating with telomerase activity. Methods: Green tea extracts were administered orally. Doxorubicin was coadministered intraperitoneally. These...

  • Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Matthias W. Laschke; Christine Schwender; Claudia Scheuer; Brigitte Vollmar; Michael D. Menger // Human Reproduction;Oct2008, Vol. 23 Issue 10, p2308 

    BACKGROUND Epigallocatechin-3-gallate (EGCG), the major component of green tea, is a pleiotropic substance, which may inhibit tumor growth via multiple intracellular signaling pathways. Herein, we studied whether EGCG may also be effective in the treatment of endometriosis. METHODS We...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics